Paper Details

  1. Home
  2. Paper Details

Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin.

Author: Ballester-FerréMaria Pilar, Garcia-GimenoNatalia, MartínezFernando, MoraFrancisco, SerraMiguel A

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

This case report describes an HCV-infected patient who developed miliary tuberculosis after completing treatment with sofosbuvir/ledipasvir plus ribavirin. This highlights the importance of considering opportunistic infections, particularly TB, in patients undergoing HCV therapy.
Paper Details　
Original Abstract of the Article :
Chronic hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. In the last 5 years, treatment for HCV infection has experienced a marked development. In 2014, the use of ledipasvir/sofosbuvir with or without concomitant weight-based ribavirin was approved wit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295150/

データ提供：米国国立医学図書館（NLM）

Miliary Tuberculosis Infection During Hepatitis C Treatment

This case report describes a patient who developed miliary tuberculosis (TB) infection while undergoing treatment for hepatitis C virus (HCV) infection with sofosbuvir and ledipasvir plus ribavirin. HCV infection is a serious liver disease that can have devastating consequences, like a relentless desert storm. The study highlights the importance of monitoring for opportunistic infections during HCV treatment.

A Hidden Threat in the Desert of HCV Treatment

The case report reveals that a patient undergoing HCV treatment developed miliary TB, a serious opportunistic infection. This is like finding a hidden scorpion in the desert, a threat that can arise unexpectedly. The case emphasizes the importance of vigilance and early detection of opportunistic infections during HCV treatment.

The Importance of Monitoring for Opportunistic Infections

The case report underscores the importance of monitoring for opportunistic infections during HCV treatment. It's like keeping a watchful eye for hidden dangers in the desert. This is a crucial step in ensuring the safety and well-being of patients undergoing HCV treatment.

Dr.Camel's Conclusion

This case report serves as a reminder that opportunistic infections can occur during HCV treatment. It's like encountering a hidden oasis in the desert, but one that harbors potential dangers. The study highlights the importance of careful monitoring and prompt treatment to prevent serious complications.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-09-30
Further Info :

Pubmed ID

28217253

DOI: Digital Object Identifier

PMC5295150

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.